Balaxi Pharmaceuticals
BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth
1d
4.2%
1w
2.6%
1m
17.6%
3m
30.8%
6m
41.0%
1y
8.4%
5y
40.1%
all
44.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 75.7 4.2%
74
127
Company Overview

Sales
264 Cr
Growth: -12.4%
Profit after Tax
32.9 Cr
Growth: -11.3%
Micro Cap
418 Cr
P/E: 11.2x
Industry P/E: 26.6x
Fundamentals

Sales (Cr) ₹ 264
Growth -12.4%
EBITDA 18.1%
P/S 1.6x
Dividend 0.0%
P/E 11.2x
Book Value ₹ 29.1
PEG Ratio -0.9x
ROE 21.8%
P/B 2.6x
Shareholding Pattern

Institutions
Elara India Opportunities Fund Limited
9.5 %
Marshal Global Capital Fund Ltd
9.5 %
Amol Anand Mantri
1.73 %
Iepf
0.75 %
Promoters
Balaxi Overseas Private Limited
70.0 %
Ashish Maheshwari
1.81 %
Minoshi Maheshwari
1.06 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.
Investors (12)
Followers (1)